Logo image of SCANA.OL

SCANA ASA (SCANA.OL) Stock Fundamental Analysis

OSL:SCANA - NO0003053308 - Common Stock

1.8 NOK
-0.01 (-0.44%)
Last: 9/10/2025, 7:00:00 PM
Fundamental Rating

3

Overall SCANA gets a fundamental rating of 3 out of 10. We evaluated SCANA against 105 industry peers in the Machinery industry. While SCANA is still in line with the averages on profitability rating, there are concerns on its financial health. SCANA has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

SCANA had positive earnings in the past year.
In the past year SCANA had a positive cash flow from operations.
Of the past 5 years SCANA 4 years were profitable.
SCANA had a positive operating cash flow in each of the past 5 years.
SCANA.OL Yearly Net Income VS EBIT VS OCF VS FCFSCANA.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M

1.2 Ratios

SCANA's Return On Assets of 0.65% is on the low side compared to the rest of the industry. SCANA is outperformed by 62.86% of its industry peers.
The Return On Equity of SCANA (1.56%) is worse than 63.81% of its industry peers.
The Return On Invested Capital of SCANA (3.15%) is worse than 65.71% of its industry peers.
Industry RankSector Rank
ROA 0.65%
ROE 1.56%
ROIC 3.15%
ROA(3y)2.29%
ROA(5y)7.89%
ROE(3y)5.28%
ROE(5y)21.93%
ROIC(3y)N/A
ROIC(5y)N/A
SCANA.OL Yearly ROA, ROE, ROICSCANA.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800 -1K

1.3 Margins

SCANA has a worse Profit Margin (0.55%) than 65.71% of its industry peers.
SCANA's Profit Margin has improved in the last couple of years.
SCANA's Operating Margin of 2.36% is on the low side compared to the rest of the industry. SCANA is outperformed by 72.38% of its industry peers.
SCANA's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 54.88%, SCANA is in the better half of the industry, outperforming 75.24% of the companies in the same industry.
SCANA's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 2.36%
PM (TTM) 0.55%
GM 54.88%
OM growth 3Y22.03%
OM growth 5Y228.51%
PM growth 3Y-21.04%
PM growth 5Y11%
GM growth 3Y5.71%
GM growth 5Y6.61%
SCANA.OL Yearly Profit, Operating, Gross MarginsSCANA.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 -60

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so SCANA is destroying value.
SCANA has more shares outstanding than it did 1 year ago.
SCANA has more shares outstanding than it did 5 years ago.
The debt/assets ratio for SCANA has been reduced compared to a year ago.
SCANA.OL Yearly Shares OutstandingSCANA.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
SCANA.OL Yearly Total Debt VS Total AssetsSCANA.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

SCANA has a debt to FCF ratio of 7.98. This is a slightly negative value and a sign of low solvency as SCANA would need 7.98 years to pay back of all of its debts.
SCANA has a Debt to FCF ratio of 7.98. This is comparable to the rest of the industry: SCANA outperforms 41.90% of its industry peers.
SCANA has a Debt/Equity ratio of 0.60. This is a neutral value indicating SCANA is somewhat dependend on debt financing.
The Debt to Equity ratio of SCANA (0.60) is worse than 65.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF 7.98
Altman-Z N/A
ROIC/WACC0.39
WACC8.08%
SCANA.OL Yearly LT Debt VS Equity VS FCFSCANA.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

SCANA has a Current Ratio of 1.03. This is a normal value and indicates that SCANA is financially healthy and should not expect problems in meeting its short term obligations.
SCANA has a worse Current ratio (1.03) than 81.90% of its industry peers.
SCANA has a Quick Ratio of 1.03. This is a bad value and indicates that SCANA is not financially healthy enough and could expect problems in meeting its short term obligations.
SCANA's Quick ratio of 0.78 is on the low side compared to the rest of the industry. SCANA is outperformed by 70.48% of its industry peers.
Industry RankSector Rank
Current Ratio 1.03
Quick Ratio 0.78
SCANA.OL Yearly Current Assets VS Current LiabilitesSCANA.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

4

3. Growth

3.1 Past

SCANA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -93.11%.
SCANA shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 21.20% yearly.
Looking at the last year, SCANA shows a small growth in Revenue. The Revenue has grown by 2.94% in the last year.
SCANA shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 39.74% yearly.
EPS 1Y (TTM)-93.11%
EPS 3Y-9.23%
EPS 5Y21.2%
EPS Q2Q%-4100%
Revenue 1Y (TTM)2.94%
Revenue growth 3Y84.93%
Revenue growth 5Y39.74%
Sales Q2Q%-31.93%

3.2 Future

Based on estimates for the next years, SCANA will show a decrease in Earnings Per Share. The EPS will decrease by -4.20% on average per year.
SCANA is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -1.05% yearly.
EPS Next Y-118.84%
EPS Next 2Y-20.75%
EPS Next 3Y-4.2%
EPS Next 5YN/A
Revenue Next Year-16.87%
Revenue Next 2Y-4.58%
Revenue Next 3Y-1.05%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
SCANA.OL Yearly Revenue VS EstimatesSCANA.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B
SCANA.OL Yearly EPS VS EstimatesSCANA.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2023 2024 2025 2026 2027 0 -0.5 -1 -1.5

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 15.00, SCANA is valued correctly.
71.43% of the companies in the same industry are more expensive than SCANA, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 27.03, SCANA is valued a bit cheaper.
Based on the Price/Forward Earnings ratio of 17.48, the valuation of SCANA can be described as rather expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of SCANA is on the same level as its industry peers.
SCANA's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.54.
Industry RankSector Rank
PE 15
Fwd PE 17.48
SCANA.OL Price Earnings VS Forward Price EarningsSCANA.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as SCANA.
SCANA's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. SCANA is cheaper than 71.43% of the companies in the same industry.
Industry RankSector Rank
P/FCF 11.98
EV/EBITDA 8.81
SCANA.OL Per share dataSCANA.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

SCANA's earnings are expected to decrease with -4.20% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.71
EPS Next 2Y-20.75%
EPS Next 3Y-4.2%

0

5. Dividend

5.1 Amount

SCANA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

SCANA ASA

OSL:SCANA (9/10/2025, 7:00:00 PM)

1.8

-0.01 (-0.44%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)05-15 2025-05-15/bmo
Earnings (Next)N/A N/A
Inst Owners0.18%
Inst Owner ChangeN/A
Ins Owners10.16%
Ins Owner ChangeN/A
Market Cap831.40M
Analysts86.67
Price Target1.94 (7.78%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.05
Dividend Growth(5Y)-61.68%
DP228.28%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-116.18%
Min EPS beat(2)-229.45%
Max EPS beat(2)-2.91%
EPS beat(4)2
Avg EPS beat(4)-19.5%
Min EPS beat(4)-229.45%
Max EPS beat(4)128.16%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-9.39%
Min Revenue beat(2)-19.55%
Max Revenue beat(2)0.77%
Revenue beat(4)2
Avg Revenue beat(4)-5.2%
Min Revenue beat(4)-19.55%
Max Revenue beat(4)9.63%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-44.12%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-175%
EPS NY rev (1m)-115.79%
EPS NY rev (3m)-115.79%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-19.74%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-18.44%
Valuation
Industry RankSector Rank
PE 15
Fwd PE 17.48
P/S 0.46
P/FCF 11.98
P/OCF 5.59
P/B 1.31
P/tB 3.28
EV/EBITDA 8.81
EPS(TTM)0.12
EY6.67%
EPS(NY)0.1
Fwd EY5.72%
FCF(TTM)0.15
FCFY8.35%
OCF(TTM)0.32
OCFY17.89%
SpS3.89
BVpS1.38
TBVpS0.55
PEG (NY)N/A
PEG (5Y)0.71
Profitability
Industry RankSector Rank
ROA 0.65%
ROE 1.56%
ROCE 4.15%
ROIC 3.15%
ROICexc 3.15%
ROICexgc 5.04%
OM 2.36%
PM (TTM) 0.55%
GM 54.88%
FCFM 3.86%
ROA(3y)2.29%
ROA(5y)7.89%
ROE(3y)5.28%
ROE(5y)21.93%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-3.16%
ROICexcg growth 5Y183.75%
ROICexc growth 3Y-15.99%
ROICexc growth 5Y161.08%
OM growth 3Y22.03%
OM growth 5Y228.51%
PM growth 3Y-21.04%
PM growth 5Y11%
GM growth 3Y5.71%
GM growth 5Y6.61%
F-Score6
Asset Turnover1.19
Health
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF 7.98
Debt/EBITDA 2.44
Cap/Depr 68.96%
Cap/Sales 4.41%
Interest Coverage 1.18
Cash Conversion 94.47%
Profit Quality 701.01%
Current Ratio 1.03
Quick Ratio 0.78
Altman-Z N/A
F-Score6
WACC8.08%
ROIC/WACC0.39
Cap/Depr(3y)42.24%
Cap/Depr(5y)32.52%
Cap/Sales(3y)2.81%
Cap/Sales(5y)1.88%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-93.11%
EPS 3Y-9.23%
EPS 5Y21.2%
EPS Q2Q%-4100%
EPS Next Y-118.84%
EPS Next 2Y-20.75%
EPS Next 3Y-4.2%
EPS Next 5YN/A
Revenue 1Y (TTM)2.94%
Revenue growth 3Y84.93%
Revenue growth 5Y39.74%
Sales Q2Q%-31.93%
Revenue Next Year-16.87%
Revenue Next 2Y-4.58%
Revenue Next 3Y-1.05%
Revenue Next 5YN/A
EBIT growth 1Y-68.07%
EBIT growth 3Y125.68%
EBIT growth 5Y359.05%
EBIT Next Year82.48%
EBIT Next 3Y36.44%
EBIT Next 5YN/A
FCF growth 1Y6.76%
FCF growth 3Y41.29%
FCF growth 5Y3.96%
OCF growth 1Y81.15%
OCF growth 3Y80.15%
OCF growth 5Y20.9%